497 related articles for article (PubMed ID: 17101314)
21. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic variability in children with eosinophilic esophagitis.
Shah A; Kagalwalla AF; Gonsalves N; Melin-Aldana H; Li BU; Hirano I
Am J Gastroenterol; 2009 Mar; 104(3):716-21. PubMed ID: 19209168
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.
Caldwell JM; Blanchard C; Collins MH; Putnam PE; Kaul A; Aceves SS; Bouska CA; Rothenberg ME
J Allergy Clin Immunol; 2010 Apr; 125(4):879-888.e8. PubMed ID: 20371398
[TBL] [Abstract][Full Text] [Related]
24. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.
Kirsch R; Bokhary R; Marcon MA; Cutz E
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):20-6. PubMed ID: 17204948
[TBL] [Abstract][Full Text] [Related]
25. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis.
Steiner SJ; Kernek KM; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):506-9. PubMed ID: 16707971
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.
Gonsalves N; Policarpio-Nicolas M; Zhang Q; Rao MS; Hirano I
Gastrointest Endosc; 2006 Sep; 64(3):313-9. PubMed ID: 16923475
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
[TBL] [Abstract][Full Text] [Related]
28. An audit of endoscopic complications in adult eosinophilic esophagitis.
Cohen MS; Kaufman AB; Palazzo JP; Nevin D; Dimarino AJ; Cohen S
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1149-53. PubMed ID: 17683993
[TBL] [Abstract][Full Text] [Related]
29. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
30. [Eosinophilic esophagitis in 29 pediatric patients].
Ferreira CT; Vieira MC; Vieira SM; Silva GS; Yamamoto DR; Silveira TR
Arq Gastroenterol; 2008; 45(2):141-6. PubMed ID: 18622469
[TBL] [Abstract][Full Text] [Related]
31. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Felder S; Kummer M; Engel H; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Gastroenterology; 2010 Nov; 139(5):1526-37, 1537.e1. PubMed ID: 20682320
[TBL] [Abstract][Full Text] [Related]
32. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Aceves SS; Bastian JF; Newbury RO; Dohil R
Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
[TBL] [Abstract][Full Text] [Related]
33. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
[TBL] [Abstract][Full Text] [Related]
34. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
[TBL] [Abstract][Full Text] [Related]
35. Non-surgical interventions for eosinophilic esophagitis.
Elliott EJ; Thomas D; Markowitz JE
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD004065. PubMed ID: 20238328
[TBL] [Abstract][Full Text] [Related]
36. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults.
Rodrigo S; Abboud G; Oh D; DeMeester SR; Hagen J; Lipham J; DeMeester TR; Chandrasoma P
Am J Gastroenterol; 2008 Feb; 103(2):435-42. PubMed ID: 18289205
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder.
Aceves SS; Newbury RO; Dohil R; Schwimmer J; Bastian JF
J Clin Gastroenterol; 2007 Mar; 41(3):252-6. PubMed ID: 17426462
[TBL] [Abstract][Full Text] [Related]
38. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.
Helou EF; Simonson J; Arora AS
Am J Gastroenterol; 2008 Sep; 103(9):2194-9. PubMed ID: 18637093
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair: a case series.
Oliveira C; Zamakhshary M; Marcon P; Kim PC
J Pediatr Surg; 2008 May; 43(5):810-4. PubMed ID: 18485944
[TBL] [Abstract][Full Text] [Related]
40. Eosinophilic esophagitis and Barrett's esophagus: an occasional association or an overlap disease? Esophageal 'double trouble' in two children.
Francalanci P; De Angelis P; Minnei F; Diomedi Camassei F; Torroni F; Dall'Oglio L; Callea F
Digestion; 2008; 77(1):16-9. PubMed ID: 18253045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
